Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Straumann Holding AG (OTCMKTS:SAUHY) was the recipient of a large decrease in short interest during the month of January. As of January 30th, there was short interest totaling 7,573 shares, a decrease of 87.0% from the January 15th total of 58,271 shares. Based on an average trading volume of 144,538 shares, the days-to-cover ratio is presently 0.1 days. Based on an average trading volume of 144,538 shares, the days-to-cover ratio is presently 0.1 days.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on SAUHY shares. Deutsche Bank Aktiengesellschaft upgraded shares of Straumann from a “hold” rating to a “buy” rating in a research note on Friday, October 31st. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a report on Monday, December 15th. The Goldman Sachs Group downgraded Straumann from a “strong-buy” rating to a “neutral” rating in a report on Monday, October 13th. Citigroup reissued a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th. Finally, UBS Group raised shares of Straumann from a “sell” rating to a “neutral” rating in a report on Tuesday, November 4th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold”.

Straumann Trading Up 1.3%

OTCMKTS:SAUHY traded up $0.17 during mid-day trading on Tuesday, hitting $13.04. The stock had a trading volume of 103,436 shares, compared to its average volume of 110,920. The company has a 50 day simple moving average of $12.04 and a 200-day simple moving average of $11.84. Straumann has a 52 week low of $10.30 and a 52 week high of $15.00.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.